Bridging of Finger-Prick Volumetric Absorptive Microsampling and Conventional Venous Sampling with Clinical Specimens for Direct Oral Anticoagulants Analysis by LC-MS/MS
Journal of Mass Spectrometry and Advances in the Clinical Lab · 08.07.2026 · 39 (1)
DOI: 10.21627/bhyw5v67 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Mass Spectrometry and Advances in the Clinical Lab, online erschienen am 08.07.2026. Verfasst von Yu-Fong Peng und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVES: Direct oral anticoagulants (DOACs) are the first-line therapy for stroke prevention in non-valvular atrial fibrillation. Exposure-response analysis has shown correlations between drug concentrations and clinical outcomes, making therapeutic drug monitoring a valuable tool. Liquid chromatography–tandem mass spectrometry (LC–MS/MS) enables sensitive and accurate quantification for clinical analysis. Volumetric absorptive microsampling (VAMS) is a minimally invasive technique for collecting dried blood specimens. However, the translation from conventional venous blood sampling to VAMS and the conversion between plasma and whole-blood concentrations remain unclear. METHODS: We developed an LC–MS/MS method for quantifying four DOACs—dabigatran, apixaban, rivaroxaban, and edoxaban—in VAMS samples and applied it to paired clinical specimens to compare venous and finger-prick blood and establish conversion factors. RESULTS: Validation results support accuracy and precision of VAMS analysis by LC–MS/MS. Comparative analysis demonstrated no significant differences in concentrations between finger-prick and venous blood for dabigatran, apixaban, and rivaroxaban. Using paired clinical samples, conversion factors were derived via weighted Deming regression: 1.88, 1.57, 1.64, and 1.08 for dabigatran (n = 30), rivaroxaban (n = 33), apixaban (n = 35), and edoxaban (n = 36), respectively. The hematocrit effect was statistically significant for dabigatran. Bland–Altman analysis showed that more than 80% of samples fell within ±20% of the mean between estimated and measured plasma concentrations. CONCLUSION: These findings support the potential clinical utility of VAMS with LC–MS/MS as an accurate and convenient tool for DOAC monitoring, facilitating future implementation of precision medicine in anticoagulation management to minimize bleeding and stroke events.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
- The Metabolomics Core Laboratory, NTU Centers of Genomic and Precision Medicine, National Taiwan University, Taipei 100, Taiwan.
- Stroke Center and Department of Neurology, National Taiwan University Hospital, Taipei 100, Taiwan.
- Department of Pharmacy, National Taiwan University Hospital, Taipei 100, Taiwan.
Zitieren
APA
Peng, Y. F., Tang, S. C., Kuo, C. H., & Lin, S. Y. (2026). Bridging of Finger-Prick Volumetric Absorptive Microsampling and Conventional Venous Sampling with Clinical Specimens for Direct Oral Anticoagulants Analysis by LC-MS/MS. Journal of Mass Spectrometry and Advances in the Clinical Lab, 39(1). https://doi.org/10.21627/bhyw5v67
Vancouver
Peng YF, Tang SC, Kuo CH, Lin SY. Bridging of Finger-Prick Volumetric Absorptive Microsampling and Conventional Venous Sampling with Clinical Specimens for Direct Oral Anticoagulants Analysis by LC-MS/MS. Journal of Mass Spectrometry and Advances in the Clinical Lab. 2026;39(1). doi:10.21627/bhyw5v67
BibTeX
@article{Peng2026,
author = {Peng, Yu-Fong and Tang, Sung-Chun and Kuo, Ching-Hua and Lin, Shin-Yi},
title = {Bridging of Finger-Prick Volumetric Absorptive Microsampling and Conventional Venous Sampling with Clinical Specimens for Direct Oral Anticoagulants Analysis by LC-MS/MS},
journal = {Journal of Mass Spectrometry and Advances in the Clinical Lab},
year = {2026},
volume = {39},
number = {1},
doi = {10.21627/bhyw5v67}
}
EUVIMED